Gülsan Yavuz

477 total citations
45 papers, 324 citations indexed

About

Gülsan Yavuz is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gülsan Yavuz has authored 45 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 12 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gülsan Yavuz's work include Lymphoma Diagnosis and Treatment (9 papers), Sarcoma Diagnosis and Treatment (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Gülsan Yavuz is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Sarcoma Diagnosis and Treatment (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Gülsan Yavuz collaborates with scholars based in Türkiye, United States and Canada. Gülsan Yavuz's co-authors include Emel Ünal, Sevgi Gözdaşoğlu, Nurdan Taçyıldız, Ayhan O. Çavdar, Emel Babacan, Figen Doğu, Mehmet Ertem, Zümrüt Uysal, Halil Özdemir and Aydan İkincioğulları and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nutrition and Cancer.

In The Last Decade

Gülsan Yavuz

41 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gülsan Yavuz Türkiye 12 78 77 69 49 47 45 324
Rita Balter Italy 12 115 1.5× 71 0.9× 46 0.7× 55 1.1× 92 2.0× 36 361
Francesca Lim Singapore 12 138 1.8× 57 0.7× 62 0.9× 41 0.8× 37 0.8× 49 350
Juan José Alegre Sancho Spain 11 28 0.4× 109 1.4× 98 1.4× 102 2.1× 41 0.9× 78 427
Omar Racchi Italy 11 105 1.3× 65 0.8× 76 1.1× 48 1.0× 123 2.6× 19 463
Seema Chhabra India 12 42 0.5× 66 0.9× 70 1.0× 112 2.3× 22 0.5× 53 429
Jorge Labrador Spain 11 97 1.2× 53 0.7× 58 0.8× 22 0.4× 168 3.6× 32 380
L. Abdelmoula Tunisia 10 33 0.4× 36 0.5× 102 1.5× 28 0.6× 88 1.9× 137 444
Santiago Rivero Chile 10 52 0.7× 103 1.3× 158 2.3× 34 0.7× 53 1.1× 13 553
Gustav Fischmeister Austria 13 92 1.2× 35 0.5× 65 0.9× 118 2.4× 159 3.4× 19 416
Alberto Tlacuilo‐Parra Mexico 12 69 0.9× 62 0.8× 33 0.5× 19 0.4× 35 0.7× 43 386

Countries citing papers authored by Gülsan Yavuz

Since Specialization
Citations

This map shows the geographic impact of Gülsan Yavuz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gülsan Yavuz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gülsan Yavuz more than expected).

Fields of papers citing papers by Gülsan Yavuz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gülsan Yavuz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gülsan Yavuz. The network helps show where Gülsan Yavuz may publish in the future.

Co-authorship network of co-authors of Gülsan Yavuz

This figure shows the co-authorship network connecting the top 25 collaborators of Gülsan Yavuz. A scholar is included among the top collaborators of Gülsan Yavuz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gülsan Yavuz. Gülsan Yavuz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ünal, Emel, et al.. (2023). Efficacy and safety of pazopanib in the treatment of pediatric sarcoma: Retrospective cohort study.. Journal of Clinical Oncology. 41(16_suppl). e23526–e23526. 1 indexed citations
2.
Karabulut, Halil Gürhan, et al.. (2018). Expression of Survivin and Its Splice Variants in Pediatric Acute Lymphoblastic Leukemia. Genetic Testing and Molecular Biomarkers. 22(12). 680–685. 1 indexed citations
3.
Bal, Sevgi Köstel, Şule Haskoloğlu, Nina K. Serwas, et al.. (2017). Multiple Presentations of LRBA Deficiency: a Single-Center Experience. Journal of Clinical Immunology. 37(8). 790–800. 34 indexed citations
4.
Yavuz, Gülsan, et al.. (2016). Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center. Journal of Clinical Immunology. 36(7). 667–676. 14 indexed citations
5.
Ünal, Emel, et al.. (2016). Serum Basic Fibroblastic Growth Factor Levels in Children with Infantile Hemangioma. The Indian Journal of Pediatrics. 83(9). 937–940. 3 indexed citations
6.
Ödek, Çağlar, Erdal İnce, Emel Ünal, et al.. (2016). An unusual case of neuroblastoma: a 17-year-old adolescent presented with bilateral diffuse lung metastasis at initial diagnosis. The Turkish Journal of Pediatrics. 58(1). 86–89. 1 indexed citations
7.
Yavuz, Gülsan, et al.. (2016). Serum IL-13 levels at diagnosis and remission in children with malignant lymphoma. The Turkish Journal of Pediatrics. 58(3). 246–253. 1 indexed citations
8.
Gözdaşoğlu, Sevgi, Emel Ünal, Ömer Uluoğlu, et al.. (2016). Secondary Neoplasms in Children with Hodgkin’s Lymphoma Receiving C-MOPP and Radiotherapy: Presentation of Four Cases. Turkish Journal of Hematology. 33(1). 66–70. 3 indexed citations
9.
Taçyıldız, Nurdan, Halil Özdemir, Gülsan Yavuz, et al.. (2014). The seroprevalence of Kaposi′s sarcoma associated herpes virus and human herpes virus-6 in pediatric patients with cancer and healthy children in a Turkish pediatric oncology center. Indian Journal of Medical and Paediatric Oncology. 35(3). 221–225. 2 indexed citations
10.
Yavuz, Gülsan, et al.. (2010). DOES SERUM SOLUBLE VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS HAVE DIFFERENT IMPORTANCE IN PEDIATRIC ACUTE LEUKEMIA AND MALIGNANT LYMPHOMA PATIENTS?. Pediatric Hematology and Oncology. 27(7). 503–516. 8 indexed citations
11.
Taçyıldız, Nurdan, Gülsan Yavuz, Emel Ünal, et al.. (2010). Soy Isoflavones Ameliorate the Adverse Effects of Chemotherapy in Children. Nutrition and Cancer. 62(7). 1001–1005. 25 indexed citations
12.
Güri̇z, Haluk, Ergi̇n Çi̇ftçi̇, Derya Aysev, et al.. (2008). Stenotrophomonas maltophiliabacteraemia in Turkish children. Annals of Tropical Paediatrics. 28(2). 129–136. 14 indexed citations
13.
Yavuz, Gülsan, Emel Ünal, İlker Ökten, et al.. (2007). THE COEXISTENCE OF THYMIC CARCINOMA AND MULTIPLE GRANULOMAS IN A TURKISH CHILD. Pediatric Hematology and Oncology. 24(4). 301–307. 6 indexed citations
14.
Yavuz, Gülsan, et al.. (2007). Fanconi anemia with the presentation of abdominal rhabdomyosarcoma followed by acute myeloid leukemia. 1 indexed citations
15.
Emir, Suna, Meltem Bingöl‐Koloğlu, Selim Erekul, et al.. (2004). Concurrent cystic mediastinal lymphangioma and paratesticular rhabdomyosarcoma. Pediatric Blood & Cancer. 43(2). 156–158. 2 indexed citations
16.
Yavuz, Gülsan, Suna Emir, Emel Ünal, et al.. (2004). Coexistence of Hodgkin Lymphoma and Cyst Hydatic Disease of the Liver. Pediatric Hematology and Oncology. 21(2). 95–99. 4 indexed citations
17.
Çavdar, Ayhan O., Gülsan Yavuz, Sevgi Gözdaşoğlu, et al.. (2001). Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: Correlation with prognostic criteria and survival. Pediatrics International. 43(4). 354–360. 18 indexed citations
18.
İkincioğulları, Aydan, Figen Doğu, Emel Babacan, et al.. (2000). NATURAL KILLER CELL NUMBERS AND CYTOTOXIC ACTIVITY IN PEDIATRIC HODGKIN DISEASE. Pediatric Hematology and Oncology. 17(2). 133–139. 2 indexed citations
19.
Ertem, Mehmet, Gülsan Yavuz, Derya Aysev, et al.. (1999). RIGHT ATRIAL CATHETER-RELATED COMPLICATIONS IN PEDIATRIC ONCOLOGY PATIENTS: The Situation in a Developing Country. Pediatric Hematology and Oncology. 16(4). 299–309. 12 indexed citations
20.
Çavdar, Ayhan O., et al.. (1993). T-Lymphocyte sub-populations in orbito-ocular granulocytic sarcoma (OOGS) and acute myelocytic leukemia (AML): A preliminary study. Medical Oncology and Tumor Pharmacotherapy. 10(3). 113–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rita Balter Breakdown of academic impact, for papers by Francesca Lim Breakdown of academic impact, for papers by Juan José Alegre Sancho Breakdown of academic impact, for papers by Omar Racchi Breakdown of academic impact, for papers by Seema Chhabra Breakdown of academic impact, for papers by Jorge Labrador Breakdown of academic impact, for papers by L. Abdelmoula Breakdown of academic impact, for papers by Santiago Rivero Breakdown of academic impact, for papers by Gustav Fischmeister Breakdown of academic impact, for papers by Alberto Tlacuilo‐Parra
Rankless by CCL
2026